Back to all webinars
Open to all ISPOR Members and Non-members
Title: Defining Value Upstream: A Canadian Success Story in Early Modeling
Wednesday, April 1, 2026
10:00AM EDT | 2:00PM UTC | 4:00PM CEST
Click here for time zone conversion
Register Now!
Description
Early modeling is a strategic tool to pinpoint the most promising use cases for new digital health and medical device technologies by optimizing clinical trial investments, guiding procurement strategy, and targeting market access pathways effectively. With most digital health solutions having an average life cycle of only three years, and a valley of death filled with promising innovations that never reach adoption, early modeling helps identify where value is generated, for whom, and how. In this project, all actors recognized the power of this methodology to inform innovation prioritization, pricing strategy, procurement considerations, and coverage readiness. This exercise clearly shifted perspectives by demonstrating the need to move from a push to a pull approach, and laying the groundwork for next steps built on key KPIs derived from the model, where accelerated discussions could lead to value-based procurement anchored on real-world evidence. In resource-constrained settings like MedTech and digital health, early economic modeling helps steer clinical research investments toward high-value opportunities. Instead of relying on ‘perfect data,’ the stakeholders embraced strategic modeling with well-founded assumptions, enabling the rapid development of a model to initiate the ‘pull’ exercise with the various decision-making parties for adoption, coverage, and next steps. Early economic modeling serves as a strategic engine, driving clinical research investments toward high-value opportunities and enabling innovators to focus resources where they can deliver the greatest impact.
Learning Objectives
- Identify the roles of local hospital evaluation units in early-stage evaluation for digital health and devices.
- Understand how early economic modeling guides prioritization of clinical studies, trial design, and market strategies.
- Evaluate stakeholder-relevant KPIs (patients, providers, payers, procurement) within early modeling scenarios.
Speakers:
Bjoern Schwander, MA, RN, PhD, General Manager & Founder, AHEAD GmbH, Bietigheim-Bissingen, Germany
Julie Frappier, MSc, President & Founder, Data 4 Actions Inc., Montreal, QC, Canada
Camille Blanckaert, BS, Strategic Advisor in Innovation in Health Sciences, UQAM , Montreal, QC, Canada
Genevieve Lavertu, MSc, Director, Government Affairs and Policy - Medical Technology, Johnson & Johnson, Markham, ON, Canada
Please note: On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 days after the scheduled Webinar.
Reservations are on a first-come, first-served basis.
